Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06361589
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-03-26
Brief Title:
Real World Study of Lolatinib for Advanced ALK NSCLC Patients
Sponsor:
Sichuan Cancer Hospital and Research Institute
Organization:
Sichuan Cancer Hospital and Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2026-11-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-11-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-26
First Submit QC Date:
April 9 2024
Study First Post Date:
2024-04-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-09
Last Update Post Date:
2024-04-12
Last Update Post Date Type:
ACTUAL